About
alterity therapeutics limited researches and develops therapeutic drugs for the treatment of parkinsonian's disease and other neurodegenerative diseases in australia. the company's lead drug candidates is ath434 that has completed phase i clinical trial fo
CEOGeoffrey Kempler
HQMelbourne, Victoria
Employees10